First International Congress on Telehealth and Multimedia Technologies Story Ideas


1. Live, Interactive Telehealth Consultations: Mon. August 16, 1999 12:30-1:15 pm - Hall C

The Craniofacial Osseointegration and Maxillofacial Prosthetic Rehabilitation Unit (COMPRU) is a world leader in head and neck reconstruction. COMPRU is one of only four clinics in the world designated as reference centres for training and development. At the Congress, two live COMPRU consultations will take place between COMPRU co-director Dr. Gordon Wilkes and:

  • Professor Per-Ingvar, a Swedish researcher who pioneered the biotechnology of osseointegration (placing metal implants into bone to anchor a prosthesis). The consultation looks at innovative technology for a finger reattachment, and a new implant technology for a mouth defect.
  • The second consultation is with Dr. Satoru Nagata, of Japan, a world leader in ear reconstruction and a plastic surgeon. The consultation involves a child patient from Saskatchewan.

3-5:00 pm - Hall A/B

Dr. Howard Gimbel, of the Gimbel Eye Centre in Calgary, will conduct eye surgery during a live consultation with Congress audience members in Edmonton.

2. Security Issues: Mon. August 16, 1999
10:30-Noon - Salon 3

An extended session on security issues and the use of digital signatures to protect information and privacy. Security firm John Ramsey and JAWS Technologies will have a live demo on "hacking information." Also, find out about the first legally approved German pilot to implement electronic signatures and encryption into a patient data exchange. The pilot employs encryption with private and public keys on smart cards and electronic signatures.

3. Impact of Cultural Diversity: Tues. August 17, 1999
10:30-NOON - HALL C


Implications of cultural diversity on telehealth applications: How will telehealth technologies affect healthcare in aboriginal communities? How will culture i

Contact: Roger Armstrong
University of Alberta

Page: 1 2 3

Related biology news :

1. First glimpse of DNA binding to viral enzyme
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. 2nd media alert First Scientific Conference on Childhood Leukaemia
4. First International Scientific Conference on Childhood Leukaemia
5. First ever standards linking climate change, biodiversity and poverty seek global peer review
6. First genetic comparison of purebred domestic dogs produces surprises
7. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
8. First target for childhood malaria vaccine
9. First study of resveratrol dietary supplement finds effect on breast and prostate cancers unlikely
10. First flavors form a lasting impression
11. STN International launches Derwent World Patents Index First View

Post Your Comments:

(Date:6/25/2020)... ... June 24, 2020 , ... eClinical Solutions LLC ... services that accelerate drug development, is collaborating with Karyopharm Therapeutics (Nasdaq: KPTI ... patients with severe COVID-19. This is the first study of an XPO1 inhibitor ...
(Date:6/23/2020)... , ... June 22, 2020 , ... The field of ... ligand binding assays (LBA) have dominated this area. However, the use of mass spectrometry ... , This now necessitates the question “How do you choose which approach to use ...
(Date:6/19/2020)... ... June 16, 2020 , ... The director of stem cell biotechnology ... the stem cell medicine and pharmaceutical industries have easier access to stem cell counting, ... July 5 of this year, Independence Day weekend in the U.S., Asymmetrex is offering ...
Breaking Biology News(10 mins):
(Date:7/1/2020)... Ohio (PRWEB) , ... June 29, 2020 , ... ... offers access to competitively procured purchasing contracts to its membership, recently named ... provide TIPS members with the opportunity to purchase ergonomic seating, cafeteria tables, book ...
(Date:6/28/2020)... ... June 25, 2020 , ... With the COVID-19 pandemic impacting ... treatment. In an effort to better understand the cellular responses to COVID-19, the ... dataset portraying therapeutic compound effects from over 1,600 approved and referenced molecules on ...
(Date:6/23/2020)... ... June 23, 2020 , ... Kerafast Inc. , ... today announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications. ... studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level ...
(Date:6/23/2020)... ... June 22, 2020 , ... ... antagonist, DRP-104, will be presented June 22-24 during the American Association for Cancer ... and, the other profiles the potent, consistent single agent activity in KEAP1 mutant ...
Breaking Biology Technology:
Cached News: